¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇѺÎÀÎÁ¾¾çÇÐȸ The 6th Biennial Meeting of Asian Society ofGynecologic Oncology (ASGO 2019), 25th Annual Symposium of KSGO 2019 : 2019-10-10

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇѺÎÀÎÁ¾¾çÇÐȸ The 6th Biennial Meeting of Asian Society ofGynecologic Oncology (ASGO 2019), 25th Annual Symposium of KSGO 2019 : 2019-10-10
±³À°ÀÏÀÚ : 2019-10-10
±³À°Àå¼Ò : ¼Ûµµ ÄÁº¥½Ã¾Æ ½Å°ü ±×·£µåº¼·ë ¹× ¼ÒȸÀǽǠ 
±³À°ÁÖÁ¦ : The 6th Biennial Meeting of Asian Society ofGynecologic Oncology (ASGO 2019), 25th Annual Symposium of KSGO 2019
ÁÖÃÖ±â°ü : ´ëÇѺÎÀÎÁ¾¾çÇÐȸ
´ã´çÀÚ : ±è¹ÎÇý
¿¬¶ôó : 02-3452-1855  
À̸ÞÀÏ : asgo2019@aim-korea.com      
±³À°Á¾·ù : »êºÎÀΰú      
Âü¼®¿¹»óÀοø : 700¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ÀÎõ±¤¿ª½Ã
±³À°½Ã°£ : 27 ½Ã°£ 35ºÐ  
¼¼ºÎ¼ö°­·á : 500,000¿ø      
ºñ°í (ÇöÀåµî·Ïºñ ±âÁØ)  ºÎÀÎÁ¾¾ç°ú/ Ÿ°ú Àü¹®ÀÇ/ Á¦¾à»ç ´ã´çÁ÷¿ø: 500,000¿ø ÀüÀÓÀÇ/¼ö·ÃÀÇ: 400,000¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 10-10 GBR A 08:30~08:45 Immune checkpoint inhibitors in gynecologic oncology  Kyung-Jin Min(Korea University) 
±³À°½Ã°£ 10-10 GBR A 08:45~09:00 Companion diagnostics and clinical biomarkers  Chel Hun Choi(Sungkyunkwan University) 
±³À°½Ã°£ 10-10 GBR A 09:00~09:15 Criteria of assessment with Imaging: iRECIST, irRECIST, irRC, RECIST1.1  Hyun Jin Choi(Chung-Ang University) 
±³À°½Ã°£ 10-10 GBR A 09:15~09:30 Management of IO agent adverse events  So Jin Shin(Keimyung University) 
±³À°½Ã°£ 10-10 GBR A 10:20~10:40 Management of PARPi adverse events  Robert Coleman(University of Texas) 
±³À°½Ã°£ 10-10 GBR A 10:40~11:00 Endometriosis-associated ovarian cancer: a challenging disease  Yutaka Osuga(University of Tokyo) 
±³À°½Ã°£ 10-10 GBR A 11:00~11:20 Laparoscopic fertility-sparing surgery for early-stage ovarian cancer  Yang Xiang(Peking Union Medical College Hospital) 
±³À°½Ã°£ 10-10 GBR A 11:20~11:40 The role of lymphadenectomy in ovarian cancer - post LIONem  Andreas du Bois(Kliniken Essen-Mitte) 
±³À°½Ã°£ 10-10 GBR A 12:30~12:50 Evolving of BRCA mutated ovarian cancer treatment: study 19  Richard Penson(Massachusetts General Hospital) 
±³À°½Ã°£ 10-10 GBR A 13:40~14:10 Toward precision medicine: evolution of global distributed research network in Korea  Rae-Woong Park(Ajou University School of Medicine) 
±³À°½Ã°£ 10-10 GBR A 14:10~14:40 Artificial Intelligence in medicine  Yoon-Sup Choi(Digital Healthcare Institute) 
±³À°½Ã°£ 10-10 GBR B 15:00~15:15 Ovarian clear cell carcinoma  Wen-Yee Chay(National Cancer Centre Singapore) 
±³À°½Ã°£ 10-10 GBR B 15:15~15:30 Uterine leiomyosarcoma  E Sun Paik(Samsung Medical Center) 
±³À°½Ã°£ 10-10 GBR B 15:30~15:45 Trophoblastic disease update  Yang Xiang(Peking Union Medical College Hospital) 
±³À°½Ã°£ 10-10 GBR B 15:45~16:00 Germ cell tumor  Hiroyuki Fujiwara(Jichi Medical University) 
±³À°½Ã°£ 10-10 GBR B 16:00~16:15 Low grade serous carcinoma  Miseon Kim(CHA University School of Medicine) 
±³À°½Ã°£ 10-10 204-205 15:00~15:20 Locally advanced cervical cancer with lymph node positive on image: Chemoradiation first?  Hyun-Cheol Kang(Seoul National University Hospital) 
±³À°½Ã°£ 10-10 204-205 15:20~15:40 What is the best sequence of chemotherapy and radiotherapy in locoregionally advanced endometrial cancer?  Jihye Cha(Yonsei University Wonju College of Medicine) 
±³À°½Ã°£ 10-10 204-205 15:40~16:00 The role of brachytherapy in the treatment of cervical cancer  Chomporn Sitathanee(Mahidol University) 
±³À°½Ã°£ 10-10 204-205 16:00~16:20 MRI-guided brachytherapy in cervical cancer in Korea  Yeon Joo Kim(National Cancer Center) 
±³À°½Ã°£ 10-10 206-207 15:00~15:10 Identification of key genes and microRNAs in cervical cancer progression by integrated bioinformatics analysis  Yuqin Zang(Tianjin Medical University General Hospital) 
±³À°½Ã°£ 10-10 206-207 15:10~15:20 The distribution and prevalence of high-risk human papillomavirus of women in western China: A meta-analysis  Mengpei Zhang(West China Second University Hospital, Sichuan University) 
±³À°½Ã°£ 10-10 206-207 15:20~15:30 Differences in the results of evaluation of quality assurance between the two methods of provision of population-based cervical cancer screening in Japan  Eiko Aoki(International University of Health and Welfare,Mita Hospital) 
±³À°½Ã°£ 10-10 206-207 15:30~15:40 A prospective randomized controlled study to compare thermal ablation with cryotherapy in cervical cancer screening  Dipanwita Banerjee(Chittaranjan National Cancer Institute) 
±³À°½Ã°£ 10-10 206-207 15:40~15:50 Application of TERC and P16 FISH in triage of ASCUS  Ying Li(Women) 
±³À°½Ã°£ 10-10 206-207 15:50~16:00 Risk factors for type-specific persistence of human papillomavirus and recurrence of cervical intraepithelial neoplasia after conization  Yung-Taek Ouh(Korea University Guro Hospital) 
±³À°½Ã°£ 10-10 206-207 16:00~16:10 Abnormal endocervical curettage (ECC) result is an independent risk factor of positive margins in conization specimen.  Jian AN(Fujian Provincial Maternity and Children¡¯s Hospital) 
±³À°½Ã°£ 10-10 206-207 16:10~16:20 GX-188E, a therapeutic HPV vaccine, in combination with imiquimod or IL-7-HYFC for treatment of HPV-16 or HPV-18 related cin 3: results from phase 2 study  Sung Jong Lee(Seoul St. Mary¡¯s Hospital) 
±³À°½Ã°£ 10-10 206-207 16:20~16:30 Quality assessment of websites providing information on HPV vaccines in Thailand  Naratassapol Likitdee(Khon Kaen University) 
±³À°½Ã°£ 10-10 GBR B 16:50~17:05 The distribution and prevalence of human papillomavirus in women in mainland China  Rutie Yin(West China Second University Hospital of Sichuan University) 
±³À°½Ã°£ 10-10 GBR B 17:05~17:20 Korean national cervical cancer screening program  Mina Suh(Korea Cancer Center) 
±³À°½Ã°£ 10-10 GBR B 17:20~17:35 Japanese population-based cervical cancer management system  Kumiko Saika(National Cancer Center, Japan) 
±³À°½Ã°£ 10-10 GBR B 17:35~17:50 Cervical cancer screening in India  Seema Singhal(All India Institute of Medical Sciences) 
±³À°½Ã°£ 10-10 GBR B 17:50~18:05 Cervical cancer screening in Myanmar  Myint Myint Thinn(Central Women¡¯s Hospital) 
±³À°½Ã°£ 10-10 204-205 16:50~17:10 Squamous cell carcinoma of the vulva and its precursors: does p53/p16 status matter?  Kyu-Rae Kim(University of Ulsan College of Medicine, Asan Medical Center) 
±³À°½Ã°£ 10-10 204-205 17:10~17:30 Mucinous ovarian tumor and pseudomyxoma  Chong Woo Yoo(National Cancer Center) 
±³À°½Ã°£ 10-10 204-205 17:30~17:50 Molecular pathology and immunohistochemistry of gynecologic malignancy  Daichi Maeda(Osaka University) 
±³À°½Ã°£ 10-10 204-205 17:50~18:10 Pathology of ovarian cancer precursors  Ren-Chin Wu(Chang Gung Memorial Hospital) 
±³À°½Ã°£ 10-10 206-207 16:50~17:00 Comparison of diagnostic accuracy between endometrial curettage and aspiration biopsy in patients treated with progestin for endometrial hyperplasia: A Korean Gynecologic Oncology Group Study  Mi Kyoung Kim(CHA Gangnam Medical Center, CHA University) 
±³À°½Ã°£ 10-10 206-207 17:00~17:10 Diagnostic accuracy of MPap¢â in women with abnormal uterine bleeding for endometrial cancer: preliminary report of a multicenter validating confirmatory study  Hung-Cheng Lai(Shuang Ho Hospital, Taipei Medical University) 
±³À°½Ã°£ 10-10 206-207 17:10~17:20 GnRH-I antagonist Cetrorelix can increase the response of endometrial cancer cells to megestrol acetate  Lijun Zhao(Peking University People¡¯s Hospital) 
±³À°½Ã°£ 10-10 206-207 17:20~17:30 The effect of combined progesterone and GnRH agonist on the growth of endometrial cancer cells  Kyungjoo Cho(School of Medicine, Gachon University, Gil Medical Center) 
±³À°½Ã°£ 10-10 206-207 17:30~17:40 Effect of Megestrol Acetate plus Metformin as Fertility-Sparing Treatment for Patients with Atypical Endometrial Hyperplasia and Well-differentiated Endometrial Cancer. A Randomized Controlled Trial  Jun Guan(Shanghai OBGYN Hospital of Fudan University) 
±³À°½Ã°£ 10-10 206-207 17:40~17:50 The oncologic outcome after long term fertility-sparing hormonal management for early stage endometrioid endometrial cancer  Su Hyun Chae(Konkuk Medical Center) 
±³À°½Ã°£ 10-10 206-207 17:50~18:00 Prolactin enhances the proliferation of endometrial glandular cells and endometrial cancer cells in conjunction with estradiol via regulation of prolactin receptor and estrogen receptor  Munekage Yamaguchi(Kumamoto University) 
±³À°½Ã°£ 10-10 206-207 18:00~18:10 Selecting endometrial cancer patients for high risk of recurrence  Ming-Yin Lin(Peter MacCallum Cancer Centre) 
±³À°½Ã°£ 10-10 206-207 18:10~18:20 Using deep learning with convolutional neural network approach to identify the invasion depth of myometrium under MR images in early stage of endometrial cancer ~ a pilot study of TSGH in Taiwan  Cheng-Chang Chang(Tri-Service General Hospital, National Defense Medical Center) 
±³À°½Ã°£ 10-10 GBR B 16:50~17:10 Elimination of cervical cancer: Global overview and prospects for Asia  Neerja Bhatla(All India Institute of Medical Sciences) 
±³À°½Ã°£ 10-10 GBR B 17:10~17:30 VIA with Picture as One Option Strategy in Increasing the Cervical Cancer Screening Coverage in Low Resource Setting area  Dwiana Ocviyanti(Universitas Indonesia AOGIN) 
±³À°½Ã°£ 10-10 GBR B 17:30~17:50 HPV test as a primary cervical cancer screening  Warner Huh(University of Alabama at Birmingham) 
±³À°½Ã°£ 10-10 GBR B 17:50~18:10 Cost-effectiveness of primary HPV test and triage test in cervical cancer screening  Wichai Termrungruanglert(Chulalongkorn University) 
±³À°½Ã°£ 10-10 GBR A 08:30~08:45 Role of GCIG on changing the practice in gynecologic cancer patients  Keiichi Fujiwara(Saitama Medical University International Medical Center) 
±³À°½Ã°£ 10-10 GBR A 08:45~09:00 Operation and harmonization for international clinical trial management  Yusuke Kajimoto(GOTIC (Gynecologic Oncology Trial and Investigation Consortium of North Kanto)) 
±³À°½Ã°£ 10-10 GBR A 09:00~09:15 Cervix & CCRN  Sang-Young Ryu(Korea Cancer Center Hospital) 
±³À°½Ã°£ 10-10 GBR A 09:15~09:30 Ovarian Cancer  Rongyu Zang(Fudan University Zhongshan Hospital) 
±³À°½Ã°£ 10-10 GBR A 09:30~09:45 Endometrial Cancer  Jae-Weon Kim(Seoul National University) 
±³À°½Ã°£ 10-10 206-207 08:30~08:40 Development and preclinical testing of Patient-derived xenograft(PDX) models for uterine cancer  Soo Young Jeong(Samsung Medical Center) 
±³À°½Ã°£ 10-10 206-207 08:40~08:50 LncRNA RP11-395G23.3, as a competitive endogenous RNA, regulate PTEN expression by sponging miR-205-5p in the progression of Endometrial Cancer  Weijuan Xin(Obstetrics and Gynecology Hospital of Fudan University) 
±³À°½Ã°£ 10-10 206-207 08:50~09:00 Calcium Channel Cav1.3 Participates in Epithelial-Mesenchymal Transition of Endometrial Cancer Cells Induced by Transforming Growth Factor ¥â  Yibo Dai(Peking University People) 
±³À°½Ã°£ 10-10 206-207 09:00~09:10 Pharmacogenomic analysis of patient-derived tumor cells in gynecologic cancers  Jeong-Won Lee(Samsung Medical Center) 
±³À°½Ã°£ 10-10 206-207 09:10~09:20 Genomic comparison of endometrioid endometrial carcinoma and its precancerous lesions  Yao Wang(Peking Union Medical College Hospital) 
±³À°½Ã°£ 10-10 206-207 09:20~09:30 Clinicopathologic significance of mismatch repair protein expression in endometrial cancer  Mi-Kyung Kim(Ewha Womans University) 
±³À°½Ã°£ 10-10 206-207 09:30~09:40 Long Term Outcome of Young Patients with Mismatch-Repair Deficient Endometrial Carcinoma  Mandy Man Yee Chu(Queen Mary Hospital, The University of Hong Kong) 
±³À°½Ã°£ 10-10 206-207 09:40~09:50 Mutation Landscape of Germline and Somatic BRCA1/2 genes in High-Grade Serous Ovarian Cancer Patients  Kyung Jin Eoh(Yonsei University College of Medicine) 
±³À°½Ã°£ 10-10 206-207 09:50~10:00 Hormone Replacement Therapy After Premature Surgical Menopause and Health Services Utilization  Ji-Hyun Jang(The University of British Columbia) 
±³À°½Ã°£ 10-10 204-205 08:30~08:50 Selected poster discussion: merits and demerits  Yoo-Young Lee(Samsung Medical Center) 
±³À°½Ã°£ 10-10 204-205 09:00~09:15 Radical hysterectomy  Dae-Yeon Kim(Asan Medical Center University of Ulsan) 
±³À°½Ã°£ 10-10 204-205 09:15~09:30 LEER  Hee-Seung Kim(Seoul National University College of Medicine) 
±³À°½Ã°£ 10-10 204-205 09:30~09:45 TMMR for cervical cancer  Rainer Kimmig(University Hospital Essen) 
±³À°½Ã°£ 10-10 204-205 09:45~10:00 PMMR for endometrial cancer  Rainer Kimmig(University Hospital Essen) 
±³À°½Ã°£ 10-10 GBR A 10:20~10:35 Overview of the current status of clinical trials in Asia  Kosei Hasegawa(Saitama Medical University International Medical Center) 
±³À°½Ã°£ 10-10 206-207 10:20~10:30 Ovarian metastasis in early-stage cervical cancer: a large single institution study  Kittipat Charoenkwan(Chiang Mai University) 
±³À°½Ã°£ 10-10 206-207 10:30~10:40 Clinical pathological analysis and prognosis prediction model of small cell carcinoma of the cervix  Chunyin Wei(Guangxi Medical University) 
±³À°½Ã°£ 10-10 206-207 10:40~10:50 Impact of learning curve on the survival of abdominal or minimally invasive radical hysterectomy for early stage cervical cancer  Hwajung Lee(Yonsei University College of Medicine) 
±³À°½Ã°£ 10-10 206-207 10:50~11:00 Impact of obesity on clinical outcomes in patients with early-stage cervical cancer after radical hysterectomy with pelvic node dissection  Kittinun Leetanaporn(Prince of Songkhla University) 
±³À°½Ã°£ 10-10 206-207 11:00~11:10 Indications of prophylactic extended-field irradiation for patients with cervical cancer  Weiping Wang(Peking Union Medical College Hospital) 
±³À°½Ã°£ 10-10 206-207 11:10~11:20 Post-irradiation PD-L1 expression predicts better prognosis after carbon ion radiotherapy in uterine cervical adenocarcinoma  Moito Iijima(Keio University School of Medicine) 
±³À°½Ã°£ 10-10 206-207 11:20~11:30 Comparisons of Radiotherapy Outcomes in Cervical Squamous Cell Carcinoma Stage IIIB with and without Lymph Node Enlargement  Fitriyadi Kusuma(Faculty of Medicine Universitas Indonesia) 
±³À°½Ã°£ 10-10 206-207 11:30~11:40 Clinical significance of centralized surveillance of hydatidiform mole: five years  Lan-zhou Jiao(Dalian Medical University) 
±³À°½Ã°£ 10-10 206-207 11:40~11:50 Gestational trophoblastic neoplasia: Determinants of outcome  Seema Singhal(All India Institute of Medical Sciences) 
±³À°½Ã°£ 10-10 204-205 10:20~10:29 Total pelvic peritonectomy for ovarian cancer with extensive peritoneal carcinomatosis in pelvic cavity  Libing Xiang(Fudan University Shanghai Cancer Center) 
±³À°½Ã°£ 10-10 204-205 10:29~10:38 Clinical anatomy required in identifying pelvic autonomic nerve system  Yasuhiko Shiki(Osaka Rosai Hospital) 
±³À°½Ã°£ 10-10 204-205 10:38~10:47 Single-port laparoscopic radical trachelectomy with fluorescent image-guided sentinel lymph node dissection  Sang Wun Kim(Yonsei Cancer Center) 
±³À°½Ã°£ 10-10 204-205 10:47~10:56 Prevention of Chylous ascites during the Robot assisted transperitoneal infrarenal paraaortic lymphadenectomy  Yoon Hee Lee(Kuyngpook national university Chilgok hospital) 
±³À°½Ã°£ 10-10 204-205 10:56~11:05 Laparoscopic primary repair of duodenal perforation after laparoscopic para-aortic lymphadenectomy  Hyeon Myeong Hong(Hanyang University College of Medicine) 
±³À°½Ã°£ 10-10 204-205 11:05~11:14 Robotic anterior exenteration for recurrent cervical cancer  Rupinder Sekhon(RGCIRC, Delhi) 
±³À°½Ã°£ 10-10 204-205 11:14~11:23 Laparoscopic extraperitoneal systematic pelvic and PARA-aortic lymphadenectomy  Supachai Raungkaewmanee(National Cancer Institute) 
±³À°½Ã°£ 10-10 204-205 11:23~11:32 Nerve sparing modified laparoscopic radical hysterectomy with vaginal cuff closure and without uterine manipulator  Dae-yeon Kim(Asan Medical Center University of Ulsan) 
±³À°½Ã°£ 10-10 204-205 11:32~11:41 Single-site robotic staging surgery for early stage ovarian cancer  Ji Geun Yoo(Seoul St. Mary) 
±³À°½Ã°£ 10-10 204-205 11:41~11:50 Combined technique of single-site robot and laparoscopy in comprehensive staging operation of endometrial cancer  Bo-Ra Lee(Chung-Ang University Hospital) 
±³À°½Ã°£ 10-10 204-205 11:10~11:25 The Role of the CRC in an Investigator Initiated Trial  Ju Yeon Yi() 
±³À°½Ã°£ 10-10 204-205 11:25~11:40 The role and environment of Research Nurse  Noriko Fujiwara(The Institute of Medical Science, The University of Tokyo) 
±³À°½Ã°£ 10-10 204-205 11:40~11:55 How to start Investigator-initiated study?  Jung-Yun Lee(Yonsei University) 
±³À°½Ã°£ 10-10 GBR A 12:10~12:30 TBD  Aikou Okamoto(The Jikei University School of Medicine) 
±³À°½Ã°£ 10-10 GBR A 13:00~13:15 Radical trachelectomy for young patients with early cervical cancer: the past and the future  Jin Li(Fudan University Shanghai Cancer Center) 
±³À°½Ã°£ 10-10 GBR A 13:15~13:30 Fertility preserving treatment of early stage endometrial cancer  Xiaojun Chen(Hospital of Fudan University) 
±³À°½Ã°£ 10-10 GBR A 13:30~13:45 Fertility preservation in early stage epithelial ovarian cancer  Hiroaki Kajiyama(Nagoya University) 
±³À°½Ã°£ 10-10 GBR A 13:45~14:00 Fertility preservation for female cancer patients  Yutaka Osuga(The University of Tokyo) 
±³À°½Ã°£ 10-10 204-205 13:00~13:15 Imaging study before cytoreductive surgery  Byung Kwan Park(Samsung Medical Center) 
±³À°½Ã°£ 10-10 204-205 13:15~13:30 Imaging follow up strategy of ovarian cancer  Jeong Yeon Cho(Seoul National University Hospital & Seoul National University College of Medicine) 
±³À°½Ã°£ 10-10 204-205 13:30~13:45 Functional Imaging of ovarian cancer  Dae Chul Jung(Yonsei University) 
±³À°½Ã°£ 10-10 204-205 13:45~14:00 Response evaluation: RECIST & iRECIST on imaging  Sung Yoon Park(Samsung Seoul Hospital) 
±³À°½Ã°£ 10-10 206-207 13:00~13:20 Ethical review of the research project  Yawana Tanapat(Bumrungrad International Hospital) 
±³À°½Ã°£ 10-10 206-207 13:20~13:40 Tips for success as a clinical investigator  Soyi Lim(Gachon University University Gil Medical Center) 
±³À°½Ã°£ 10-10 206-207 13:40~14:00 Transparency in medical writing  Seung-Hyuk Shim(Konkuk University) 
±³À°½Ã°£ 10-10 GBR A 14:05~14:20 Post chemotherapy quality of life in developing country  Hariyono Winarto(Universitas Indonesia) 
±³À°½Ã°£ 10-10 GBR A 14:20~14:35 Hypersensitivity reactions to carboplatin and paclitaxel: management and oncologic outcomes  Suwanit Therasakvichya(Siriraj Hospital, Mahidol University) 
±³À°½Ã°£ 10-10 GBR A 14:35~14:50 Hospice care by specialist palliative care team  Yoon Jung Chang(National Cancer Center) 
±³À°½Ã°£ 10-10 GBR A 14:50~15:05 Pain control in patients with advanced stage cancer  Seyoung Seo(Asan Medical Center) 
±³À°½Ã°£ 10-10 206-207 14:05~14:15 Bevacizumab maintenance therapy extended the overall survival for the histopathological mesenchymal transition type of high-grade serous ovarian carcinoma.  Kentaro Ishida(Nagahama Red Cross Hospital) 
±³À°½Ã°£ 10-10 206-207 14:15~14:25 Additional chemotherapy in epithelial ovarian cancer with residual disease after six cycles of postoperative adjuvant chemotherapy  Se Ik Kim(Seoul National University College of Medicine) 
±³À°½Ã°£ 10-10 206-207 14:25~14:35 Preliminary experience of hyperthermic intraperitoneal chemotherapy after debulking surgery for ovarian cancer  Wei-Chun Chen(Chang Gung Memorial Hospital of Linkou Branch) 
±³À°½Ã°£ 10-10 206-207 14:35~14:45 Enhanced chemotherapy effects on gynecological cancers by using the combination of lipid bubble and ultrasound  Kohei Yamaguchi(The University of Tokyo) 
±³À°½Ã°£ 10-10 206-207 14:45~14:55 Doxorubicin-loaded oligonucleotide conjugated gold nanoparticles: a promising drug delivery system for ovarian cancer  Hyeji Jeon(Soonchunhyang university Cheonan hospital) 
±³À°½Ã°£ 10-10 206-207 14:55~15:05 The influence of depression on health utility value in patients with gynecologic cancer : A comparison with physical symptoms and performance status  Ye Lee Yu(National Cancer Center) 
±³À°½Ã°£ 10-10 204-205 14:05~14:20 Surgical technique : radical upper abdominal dissection/resection  Suk-Joon Chang(Ajou University School of Medicine) 
±³À°½Ã°£ 10-10 204-205 14:20~14:35 Surgical technique : radical pelvic dissection/resection  Kazuyoshi Kato(Tokyo Medical University) 
±³À°½Ã°£ 10-10 204-205 14:35~14:50 MSKCC resectability score and selection criteria for primary debulking surgery  Dennis Chi(Memorial Sloan Kettering Cancer Center) 
±³À°½Ã°£ 10-10 204-205 14:50~15:05 Role of lymphadenectomy in ovarian cancer  Jianqing Zhu(Zhejiang Cancer Hospital) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇѺÎÀÎÁ¾¾çÇÐȸ The 6th Biennial Meeting of Asian Society ofGynecologic Oncology (ASGO 2019), 25th Annual Symposium of KSGO 2019 : 2019-10-10""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇÑ¿µ»óÀÇÇÐȸ ´ëÀüÃæ³²Áöȸ : 2019-10-10
´ÙÀ½±Û ¿ø±¤´ëÇб³º´¿ø 2019³âµµ Ãß°è ´ëÇÑÀ̺ñÀÎÈÄ°úÇÐȸ ÀüºÏÁöºÎ Çмú´ëȸ ¹× ¿¬¼ö°­Á : 2019-10-10
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20925 ÀüºÏ Á¦ 53Â÷ ´ëÇѳëÀκ´ÇÐȸ È£³²Áöȸ ÇмúÁý´äȸ : 2024-07-27 0 34 2024-05-28
20924 ¼­¿ï 2024 Á¦27ȸ ´ëÇѾȸ鼺ÇüÀç°ÇÇÐȸ Ãá°è Çмú´ëȸ : 2024-07-21 0 34 2024-05-28
20923 °æ±â 2024³â ÀÏ»ê¹éº´¿ø Á¤Çü¿Ü°ú ½ÉÆ÷Áö¾ö : 2024-07-21 0 30 2024-05-28
20922 ¼­¿ï 2024³â ü°èÀû ¹®Çå°íÂû(¸ÞŸºÐ¼®) ³í¹®Ãâ°£ ¿öÅ©¼¥ 2Â÷(2ÀÏÂ÷) : 2024-07-20 0 25 2024-05-28
20921 ¼­¿ï Á¦33Â÷ ´ç´¢º´ ¿¬±¸ ÇÏ°è¿öÅ©¼¥ : 2024-07-20 0 29 2024-05-28
20920 ¼­¿ï ´ëÇÑÁ¾¾ç³»°úÇÐȸ Recent updates in GU Cancers 2024 : 2024-07-19 0 40 2024-05-28
20919 ¼­¿ï 2024³â ü°èÀû ¹®Çå°íÂû(¸ÞŸºÐ¼®) ³í¹®Ãâ°£ ¿öÅ©¼¥ 2Â÷(1ÀÏÂ÷) : 2024-07-19 0 17 2024-05-28
20918 ¼­¿ï [¿Â¶óÀÎ] Áø´Ü¿ë ¹æ»ç¼± ¾ÈÀü°ü¸®Ã¥ÀÓÀÚ ¼±ÀÓ±³À° : 2024-07-14 0 23 2024-05-28
20917 °æºÏ 2024³â ´ëÇÑ°ñ´Ù°øÁõÇÐȸ ¿µ³² ¿¬¼ö°­Á : 2024-07-14 0 22 2024-05-28
20916 °æ±â ÀÎÁ¦´ëÇб³ ÀÏ»ê¹éº´¿ø ¼ÒÈ­±â³»°ú °³¿øÀÇ ¿¬¼ö°­Á : 2024-07-13 0 21 2024-05-28
20915 °æ±â 2024³â ÀÇÁ¤ºÎÀ»Áö´ëÇб³º´¿ø Á¦1ȸ ½Å°æ°ú °³¿øÀÇ ¿¬¼ö±³À° : 2024-07-13 0 21 2024-05-28
20914 ºÎ»ê Á¦6ȸ ºÎ»ê¼º¸ðº´¿ø ¼Ò¾Æû¼Ò³â°ú ½ÉÆ÷Áö¾ö : 2024-07-13 0 19 2024-05-28
20913 ¼­¿ï 2024 ´ëÇѽŰ泻ºÐºñ¿¬±¸È¸ ¿¬¼ö°­Á : 2024-07-13 0 22 2024-05-28
20912 ¼­¿ï ÀºÆò±¸ÀÇ»çȸ Á¦3Â÷¿¬¼ö±³À° : 2024-07-11 0 24 2024-05-28
20911 ¼­¿ï (¿Â¶óÀÎ) 2024³â ¼Ò¾Æ½ÅÀå Post-graduate education course : 2024-07-08 0 26 2024-05-28
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷